Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Terveystalo Plc - Managers' transactions - Laurila

Terveystalo Plc - Managers' transactions, 9 March, 2022 at 14:30 EET ____________________________________________ Person subject to the notification requirement Name: Laurila, Ilkka Position: Chief Financial Officer Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20220308134901_32 ____________________________________________ Transaction date: 2022-03-08 Venue not applicable Instrument type: SHARE ISIN: FI4000252127 Nature of the transaction: RECEIPT OF A SHARE-BASED

Terveystalo Plc - Managers' transactions - Juosila

Terveystalo Plc - Managers' transactions, 9 March, 2022 at 14:30 EET ____________________________________________ Person subject to the notification requirement Name: Juosila, Juha Position: Other senior manager Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20220308134901_31 ____________________________________________ Transaction date: 2022-03-08 Venue not applicable Instrument type: SHARE ISIN: FI4000252127 Nature of the transaction: RECEIPT OF A SHARE-BASED

Terveystalo Plc - Managers' transactions - Saksi

Terveystalo Plc - Managers' transactions, 9 March 2022 at 14:30 EET ____________________________________________ Person subject to the notification requirement Name: Saksi, Siina Position: Other senior manager Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20220308134901_33 ____________________________________________ Transaction date: 2022-03-08 Venue not applicable Instrument type: SHARE ISIN: FI4000252127 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Terveystalo Plc - Managers' transactions - Keksi

Terveystalo Plc - Managers' transactions, 9 March 2022 at 14:30 EET ____________________________________________ Person subject to the notification requirement Name: Keksi, Petri Position: Other senior manager Issuer: Terveystalo Plc LEI: 7437001AEZHLL3UEX093 Notification type: INITIAL NOTIFICATION Reference number: 7437001AEZHLL3UEX093_20220308134901_34 ____________________________________________ Transaction date: 2022-03-08 Venue not applicable Instrument type: SHARE ISIN: FI4000252127 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

ITAB discontinues its operations in Russia

ITAB Shop Concept AB (publ) (“ITAB”) has decided to discontinue its operations in Russia due to the ongoing invasion of Ukraine.ITAB has a production facility and sales offices in Russia with a total of approximately 125 employees. ITAB currently has no operations in Ukraine. The decommissioning process begins immediately with due considerations towards employees, customers, and business partners. “Many at ITAB have colleagues, family or friends who are affected by the current situation in Ukraine. ITAB takes a firm stand against all forms of abuse and we cannot continue our activities

A New Era of DeFi Applications Set to Take Blockchain Mainstream - Open for Grants!

Concordium’s Reg DeFi Lab now accepting grant applications Zurich, Switzerland - March 9th, 2022 – The Concordium Reg DeFi Lab, launched by Concordium and Verum Capital, is the first lab for regulated decentralized finance projects. It aims to support and fund projects developing the next generation of DeFi products and services with a community endowment program of 650M CCDs. Concordium and Verum Capital forecast that the next generation of DeFi applications will facilitate enterprise and institutional client adoption.The opportunities that Web3 offers have become undeniable. Current

Official start of the urban development project Mera Älta

Today, Wallenstam together with Nacka Municipality is conducting an inauguration ceremony for the urban development project Mera Älta. With around 1,250 new apartments in progress along with expanded services, restaurants, cultural amenities and new meeting places, Wallenstam together with Nacka Municipality wants to highlight the holistic nature of the project. CEO Hans Wallenstam and Chairman of the Municipal Executive Board Mats Gerdau are today unveiling the construction work sign and are making hand castings on-site.Wallenstam’s new construction project in central Älta involves seven

Evolution: NOTICE OF ANNUAL GENERAL MEETING

Evolution AB (publ), 556994-5792, holds an annual general meeting on Friday 8 April 2022. Due to the risk of the spread of the coronavirus (COVID-19), the board has decided that the annual general meeting shall be held without physical presence of shareholders, proxies and/or external parties and that the shareholders shall have the opportunity to vote by post prior to the general meeting. REGISTRATION AND NOTIFICATION Those who wish to attend the annual general meeting must: · be entered as a shareholder in the share register kept by Euroclear Sweden AB on Thursday 31 March

PLAGAZI AB (PUBL) AND POWERCELL AB (PUBL) INITIATES COLLABORATION FOR KÖPING HYDROGEN PARK, VIA ORDER OF PRE-STUDY

Plagazi AB (publ) (“Plagazi” or the “Company”) has contracted PowerCell Sweden AB (publ) (“PowerCell”) to conduct a pre-study investigating the feasibility to utilize PowerCell’s innovative fuel cell technology in Köping Hydrogen Park. PowerCell Sweden offers the most compact and robust fuel cell systems on the market which can be utilized as a sustainable back-up generator for Köping Hydrogen Park or as a converting mechanism to enable Plagazi to sell green electricity produced from green hydrogen, directly to the power grid while also providing district heating to the municipality of Köping.

New funding to help 16-24 years olds ‘step up’ to higher education

Staffordshire University has received a funding boost to help break down barriers to higher education for young people across the region.For more than 10 years, the Step Up to Higher Education  course has been supporting students who want to return to education and develop the key academic skills needed for university level study. To date, the course has worked with some of Stoke-on-Trent’s most disadvantaged learners. Thanks to funding from the Community Renewal Fund, the University is now looking to widen its reach with help

Keliber Performs Well in Emissions Comparison

Keliber has analysed the CO2 emissions generated by its future production in two studies. Based on the comparative study, Keliber’s lithium hydroxide will have a smaller carbon footprint than most of the competitors’ products. The production is planned to begin in 2024.Keliber benefits from its integrated production process. The ore is extracted and processed at less than 70 kilometres from the lithium chemical plant, where the refining process is energy efficient. More than half of the electricity from the Finnish national grid is generated from renewable energy sources. In addition,

GF Piping Systems & Foreship Study: Pre-insulated plastic piping systems make passenger ships more efficient

Due to increasing sustainability regulations, the maritime industry is in need of technical solutions that are highly efficient but also financially viable. As a new study by GF Piping Systems and Foreship shows, HVAC applications on passenger ships offer significant potential for improvement. Comparing a baseline steel piping system with pre-insulated polyethylene pipes in an air conditioning chilled water system revealed that plastic is more efficient in four areas: It decreases fuel consumption, reduces greenhouse gas emissions, lowers costs, and slightly improves EEXI and CII values.

Karo Pharma applies for delisting of the Company’s shares from Nasdaq Stockholm, in connection with the change of listing venue to Nasdaq First North Growth Market

The Board of Directors of Karo Pharma Aktiebolag (publ) (the “Company” or “Karo Pharma”) has today decided to apply for and submitted the application regarding delisting of the Company’s shares from Nasdaq Stockholm as well as decided to apply for listing of the Company’s shares on Nasdaq First North Growth Market (the “First North-listing”).As communicated on 15 December 2021, the Board considers that Nasdaq First North Growth Market, with its more suitable regulatory environment and lower cost of complying with continuing obligations, is a more appropriate listing venue for the Company

Notice of annual general meeting of H+H International A/S

The Board of Directors of H+H International A/S hereby invites the company’s shareholders to attend the annual general meeting of H+H International A/S on Thursday 31 March 2022 at 11.00 am CET at Comwell Copenhagen Portside, Alexandriagade 1, 2150 Nordhavn, Denmark. The meeting will be transmitted live for shareholders via a link on the H+H Shareholder Portal at www.HplusH.com/hh-shareholder-portal, but please note that the transmission is view-only and thus does not enable formal participation in the general meeting with access to vote and speak. Shareholders viewing the general

Skogluft spreads its mission worldwide with a unique certification program

The Norwegian growth company is currently launching its living walls internationally. The launch of Skogluft Academy is furthering the company's mission of reconnecting people with nature.The three-month digital course is now open for people around the world to become Certified Skogluft Indoor Nature Consultants. Skogluft Academy is the only certification program of its kind, training the participants to be specialists in bringing nature indoors.  – Everyone who wants to make our indoor spaces greener, calmer, healthier and happier places to live is welcome to join the English-spoken

The European Medicines Agency extends the shelf life of the antigens used in Strangvac to 28 months.

Stockholm, March 9, 2022 - The European Medicines Agency has today, after reviewing stability data, approved the extension of the shelf life of the antigens in Strangvac to 28 months. The manufacturing of Strangvac, a vaccine against the highly contagious equine disease strangles, takes place in two steps - first the antigens are produced in a process that yields sufficient antigens for several million doses, then vaccine doses are produced by mixing the antigens with adjuvant and saline. The reconstituted vaccine doses are transferred into vials that are labelled and packaged for sale.

ADDvise receives allocation decision worth approximately SEK 44 million

ADDvise Group AB (publ)’s subsidiary Hettich Labinstrument AB has received an allocation decision from Region Stockholm-Gotland worth approximately SEK 44 million. The allocation decision consists of delivery of blood specimen collection equipment during a four-year period starting May 2022. The allocation decision is subject to an appeal time expiring 18 March 2022. For further information, please contact:Rikard Akhtarzand, CEO+46 765-25 90 71rikard.akhtarzand@addvisegroup.se Important information: This information is by ADDvise Group AB required to disclose under the EU

Change in Zengun Group AB’s management

Stefan Lindh, CFO of Zengun Group AB (publ), is stepping down at his own request. Stefan Lindh has been part of Zengun from the very start and has held roles in all parts of the Group’s accounting and treasury function. He will remain with the company for a transitional period to safeguard the handover to those who take over to continue developing Zengun. “Stefan is a valued colleague who has been part of laying the foundations for the Zengun we have today. His knowledge has contributed to the financial stability the company currently enjoys. I would like to take this opportunity to

Cellnex and SEGULA Technologies enter a partnership to expand Private 5G Network capabilities into the Automotive Industry

· With this partnership, SEGULA Technologies will be able to offer its automotive customers a private 5G network at its huge proving ground in Rodgau-Dudenhofen, Germany. · By joining capabilities, both companies have the ability to expand into the new era of vehicle automation and to strengthen their position as customer-focused and future-oriented solutions providers.Cellnex Telecom has launched its partnership with the automotive branch of SEGULA Technologies, a global engineering group specializing in full-service solutions for major industrial sectors. Deployed through its

Quartiers publishes information brochure regarding the exercise of series 4 (TO4) warrants

The brochure will be sent to all shareholders and warrant holders by post, but is also available on the company's website www.quartiersproperties.se.The subscription price per ordinary share on exercising a warrant is the highest of (i) 75 percent of the volume-weighted average price according to Nasdaq First North Growth Market’s official list of prices for the shares for a period of ten trading days immediately prior to (and excluding) 15 March 2022, and (ii) SEK 3.50. The subscription price will be announced in a press release around 15 March 2022.

Quartiers publishes information brochure regarding the exercise of series 4 (TO4) warrants

The brochure will be sent to all shareholders and warrant holders by post, but is also available on the company's website www.quartiersproperties.se.The subscription price per ordinary share on exercising a warrant is the highest of (i) 75 percent of the volume-weighted average price according to Nasdaq First North Growth Market’s official list of prices for the shares for a period of ten trading days immediately prior to (and excluding) 15 March 2022, and (ii) SEK 3.50. The subscription price will be announced in a press release around 15 March 2022.

EUROSTARS supported ASTORIA study using Pilloxa’s digital medication adherence solution in cardiovascular disease patients begins

Stockholm, Sweden, March 9, 2022: Digital health company Pilloxa today announced that the First Patient First Visit milestone has been reached in the ASTORIA* study – a single-armed and multicenter observational clinical trial in which their digital patient-centric adherence solution is being tested in cardiovascular disease patients, namely newly diagnosed patients with atrial fibrillation. Professor Dan Atar from the University of Oslo is the sponsor of the study, financial support is provided by an EU-grant from the EUROSTARS program and Bayer.The primary objective of the study is to

Notice of Annual Shareholders’ Meeting of Dometic Group AB (publ)

The shareholders in Dometic Group AB (publ) (Reg. No. 556829-4390) are hereby summoned to the annual shareholders' meeting on Wednesday, April 13, 2022 at 1.00 pm at Clarion Hotel Sign, Östra Järnvägsgatan 35, SE-111 20 Stockholm. Registration starts at 12.30 pm. The board of directors has decided that the shareholders will also be able to exercise their voting rights in advance (postal voting) in accordance with the Articles of Association. Due to the continued spread of the corona virus, Dometic encourages its shareholders to consider making use of the possibility to participate by

Nanoscribe introduces Extra Large Feature Print Set to extend 3D Microfabrication capabilities to print centimetre-sized structures

3D printing based on Two-Photon Polymerization closes gap with high-resolution DLP and projection micro stereolithography (PµSL)Nanoscribe, a BICO company, introduces the Extra Large Features (XLF) Print Set, to expand the manufacturing range for its high-precision 3D printer Quantum X shape from nano- and microscale structures to millimeter- and centimeter-sized objects, while maintaining particularly complex structures and filigree details as is the case in many biomedical and microfluidic applications. But above all, the new XLF Print Set speeds up high-precision 3D printing many times

There are no items matching the current filter
There are no more items matching the current filter
Back to top